FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Nitrofurantoin 50mg capsules (Morningside Healthcare Ltd) 30 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitrofurantoin 50mg capsules (Morningside Healthcare Ltd) 30 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitrofurantoin 100mg capsules (Morningside Healthcare Ltd) 30 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitrofurantoin 100mg capsules (Morningside Healthcare Ltd) 30 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Allopurinol 100mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Allopurinol 100mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Allopurinol 300mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Allopurinol 300mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amiodarone 200mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amiodarone 200mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 1mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 1mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 1mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Fluoxetine 10mg capsules (Morningside Healthcare Ltd) 30 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Fluoxetine 10mg capsules (Morningside Healthcare Ltd) 30 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 50 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 3mg buccal tablets (Morningside Healthcare Ltd) 50 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 250mg tablets (Ennogen Pharma Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 250mg tablets (Ennogen Pharma Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Viatris UK Healthcare Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Viatris UK Healthcare Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Viatris UK Healthcare Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Viatris UK Healthcare Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Viatris UK Healthcare Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Viatris UK Healthcare Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 4mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 4mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Furosemide 20mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Furosemide 20mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 125mg tablets (Ennogen Pharma Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 125mg tablets (Ennogen Pharma Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 500mg tablets (Ennogen Pharma Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 500mg tablets (Ennogen Pharma Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitrazepam 5mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitrazepam 5mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ranitidine 150mg tablets (Ennogen Pharma Ltd) 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ranitidine 150mg tablets (Ennogen Pharma Ltd) 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ranitidine 300mg tablets (Ennogen Pharma Ltd) 30 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 250mg gastro-resistant tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 250mg gastro-resistant tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Doxazosin 8mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Doxazosin 8mg tablets (Ennogen Pharma Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    CanesOasis Cystitis Relief 4g oral granules sachets (Bayer Plc) 6 sachet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    CanesOasis Cystitis Relief 4g oral granules sachets (Bayer Plc) 6 sachet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 250mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 250mg tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ocufresh 0.3% eye drops (Blumont Healthcare Ltd) 10 ml Has concentration strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ocufresh 0.3% eye drops (Blumont Healthcare Ltd) 10 ml Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Melkine 1.5mg tablets (Crescent Pharma Ltd) 1 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Melkine 1.5mg tablets (Crescent Pharma Ltd) 1 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Allerief 4mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Allerief 4mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 60 tablet 6 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Bisacodyl 5mg gastro-resistant tablets (Medreich Plc) 60 tablet 6 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Paracetamol 500mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Paracetamol 500mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Paracetamol 500mg tablets (Medreich Plc) 32 tablet 4 x 8 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Paracetamol 500mg tablets (Medreich Plc) 32 tablet 4 x 8 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Paracetamol 500mg tablets (Medreich Plc) 16 tablet 2 x 8 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Paracetamol 500mg tablets (Medreich Plc) 16 tablet 2 x 8 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cimetidine 200mg tablets (Medreich Plc) 60 tablet 3 x 20 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cimetidine 200mg tablets (Medreich Plc) 60 tablet 3 x 20 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cimetidine 400mg tablets (Medreich Plc) 60 tablet 6 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cimetidine 400mg tablets (Medreich Plc) 60 tablet 6 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Losartan 100mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Losartan 100mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Naproxen 500mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Naproxen 500mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 3mg buccal tablets (Medreich Plc) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 3mg buccal tablets (Medreich Plc) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prochlorperazine 5mg tablets (Medreich Plc) 84 tablet 6 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prochlorperazine 5mg tablets (Medreich Plc) 84 tablet 6 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ibuprofen 400mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ibuprofen 400mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ibuprofen 600mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ibuprofen 600mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cimetidine 800mg tablets (Medreich Plc) 30 tablet 3 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cimetidine 800mg tablets (Medreich Plc) 30 tablet 3 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Isosorbide mononitrate 20mg tablets (Medreich Plc) 56 tablet 4 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Isosorbide mononitrate 20mg tablets (Medreich Plc) 56 tablet 4 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Hydroxyzine 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Hydroxyzine 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets (Medreich Plc) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Losartan 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Losartan 25mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Losartan 50mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Losartan 50mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tetracycline 250mg tablets (Genesis Pharmaceuticals Ltd) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tetracycline 250mg tablets (Genesis Pharmaceuticals Ltd) 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 316 of 342 Next End

    This concept is not in any reference sets

    Back to Start